Efficiency and safety of neoadjuvant PD-1 inhibitor (penpulimab) combined with chemotherapy in resectable N1/N2 nonsmall cell lung cancer: a prospective cohort study.

Int J Surg · 2025 · PMC12430833 · PMID 40503768

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

We analyzed survival associations: nodal downstaging demonstrated a nonsignificant trend toward improved PFS, contrasting with Du et al ’s findings [ 18 ] where complete nodal clearance predicted superior DFS/OS.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.